Review

apolipoprotein a1 (Bruker Corporation)

Bruker Corporation is a verified supplier

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Bruker Corporation apolipoprotein a1
$(A-B) Bar plots compare the impact (delta change: Day 4-Day 1) of Diet 1 and Diet 2 on lipids and lipoprotein and LDL subfractions. q-values are shown above the bars. (C) Microbial richness was significantly lower after Diet 2 compared to Diet 1 on Day 4 (after 72 h). (D-E) Shannon and Simpson diversity on Day 4 showed trends towards lower values after Diet 2 than Diet 1. (F-G) Within Diet 2, both Shannon and Simpson diversity showed trends toward a decrease from baseline to Day 4. Data are presented as median with interquartile range. p-values are shown above the corresponding bars. Diet 1 is shown in green; Diet 2 in red. Abbreviations: CH, Cholesterol; LDL-C, low density lipoproteins cholesterol; LDL-PL, low density lipoprotein phospholipids; Apo-B100, <t>apolipoprotein-B100;</t> PN, particle number; FC, free cholesterol; PL, phospholipids.$
Apolipoprotein A1, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/amix/med_rxiv__64898__2026__03__20__26348884-68-27-47?v=Bruker+Corporation
Average 96 stars, based on 1 article reviews

apolipoprotein a1 - by Bioz Stars, 2026-08

96/100 stars

Images

1) Product Images from "Metabolic Phenotyping Objectively Captures Dietary Intake and Short-term Cardiovascular Disease Risk Responses Under an Inpatient Randomized Crossover Clinical Trial"

Article Title: Metabolic Phenotyping Objectively Captures Dietary Intake and Short-term Cardiovascular Disease Risk Responses Under an Inpatient Randomized Crossover Clinical Trial

Journal: medRxiv

doi: 10.64898/2026.03.20.26348884

$(A-B) Bar plots compare the impact (delta change: Day 4-Day 1) of Diet 1 and Diet 2 on lipids and lipoprotein and LDL subfractions. q-values are shown above the bars. (C) Microbial richness was significantly lower after Diet 2 compared to Diet 1 on Day 4 (after 72 h). (D-E) Shannon and Simpson diversity on Day 4 showed trends towards lower values after Diet 2 than Diet 1. (F-G) Within Diet 2, both Shannon and Simpson diversity showed trends toward a decrease from baseline to Day 4. Data are presented as median with interquartile range. p-values are shown above the corresponding bars. Diet 1 is shown in green; Diet 2 in red. Abbreviations: CH, Cholesterol; LDL-C, low density lipoproteins cholesterol; LDL-PL, low density lipoprotein phospholipids; Apo-B100, apolipoprotein-B100; PN, particle number; FC, free cholesterol; PL, phospholipids.$
Figure Legend Snippet: (A-B) Bar plots compare the impact (delta change: Day 4-Day 1) of Diet 1 and Diet 2 on lipids and lipoprotein and LDL subfractions. q-values are shown above the bars. (C) Microbial richness was significantly lower after Diet 2 compared to Diet 1 on Day 4 (after 72 h). (D-E) Shannon and Simpson diversity on Day 4 showed trends towards lower values after Diet 2 than Diet 1. (F-G) Within Diet 2, both Shannon and Simpson diversity showed trends toward a decrease from baseline to Day 4. Data are presented as median with interquartile range. p-values are shown above the corresponding bars. Diet 1 is shown in green; Diet 2 in red. Abbreviations: CH, Cholesterol; LDL-C, low density lipoproteins cholesterol; LDL-PL, low density lipoprotein phospholipids; Apo-B100, apolipoprotein-B100; PN, particle number; FC, free cholesterol; PL, phospholipids.

Techniques Used:

Similar Products

Image Search Results

Journal: medRxiv

Article Title: Metabolic Phenotyping Objectively Captures Dietary Intake and Short-term Cardiovascular Disease Risk Responses Under an Inpatient Randomized Crossover Clinical Trial

doi: 10.64898/2026.03.20.26348884

Figure Lengend Snippet: (A-B) Bar plots compare the impact (delta change: Day 4-Day 1) of Diet 1 and Diet 2 on lipids and lipoprotein and LDL subfractions. q-values are shown above the bars. (C) Microbial richness was significantly lower after Diet 2 compared to Diet 1 on Day 4 (after 72 h). (D-E) Shannon and Simpson diversity on Day 4 showed trends towards lower values after Diet 2 than Diet 1. (F-G) Within Diet 2, both Shannon and Simpson diversity showed trends toward a decrease from baseline to Day 4. Data are presented as median with interquartile range. p-values are shown above the corresponding bars. Diet 1 is shown in green; Diet 2 in red. Abbreviations: CH, Cholesterol; LDL-C, low density lipoproteins cholesterol; LDL-PL, low density lipoprotein phospholipids; Apo-B100, apolipoprotein-B100; PN, particle number; FC, free cholesterol; PL, phospholipids.

Article Snippet: Fasting serum sample collected at baseline and after 72 h of adherence to dietary interventions were analyzed for glucose, triglyceride, cholesterol, LDL-C, HDL-C, LDL phospholipids (LDL-Phos), HDL-PL, apolipoprotein A1 (ApoA1), Apo-B100 and the glycoprotein signal (Glycs), α1-acid glycoprotein A (GlycA), α1-acid glycoprotein B (GlycB) were measured using Bruker PhenoRisk PACS TM methods ( – ).

Techniques: